Genomic & Biopharma News

Japanese study on SARS-CoV-2 breakthrough infections
Researchers evaluated SARS-CoV-2 incidence in Japan regarding the timing of the vaccination program and surge in COVID-19 cases among the staff of a large referral hospital in Tokyo. This study is posted to the medRxiv* preprint server.
News Medical Life Sciences, 2021-10-28 05:59:33

N antibodies following SARS-CoV-2 Alpha and Delta infections by vaccination status
A new study, published on the medRxiv* preprint server, has focused on the use of anti-nucleocapsid (N) antibody positivity as a marker of SARS-CoV-2 infection. In the present study, these antibody markers were evaluated using serological surveillance studies post-vaccination amidst circulation of variants of concern.
News Medical Life Sciences, 2021-10-28 05:38:51

COVID-19: Clinical Pathways to Pandemic Relief
By Graeme Gardner, Ph.D.
ORB Company Blog, 2020-03-26 19:58:16

Routine surveillance helps detect asymptomatic SARS-CoV-2 vaccine breakthrough infections
In a study published in Annals of Internal Medicine, researchers from Italy systematically monitored 2,397 HCWs who were fully vaccinated with BNT162 at the ASST Settelaghi hospitals in Lombardy, Italy during February 2021. HCWs who worked in 8 wards deemed at “high risk” for infection from attending patients had to undergo mandatory nasopharyngeal swab testing with SARS-CoV-2 polymerase chain reaction every two weeks. HCWs working in 8 “moderate-risk” wards were tested every four weeks.
News Medical Life Sciences, 2021-10-28 05:21:22

COVID vaccines deployed in US highly effective at reducing hospitalizations and deaths
Researchers in the United States have conducted a large-scale study showing that the two-dose regimen vaccines developed by Pfizer-BioNTech and Moderna to protect against coronavirus disease 2019 (COVID-19) appear to be highly effective and durable in reducing the risk of hospitalizations and deaths following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
News Medical Life Sciences, 2021-10-28 04:57:19

SARS-CoV-2 vaccination lowers risk of several outcomes after breakthrough infection
Researchers at the University of Oxford have conducted a study showing that vaccination against coronavirus disease 2019 (COVID-19) is associated with a lower risk of several sequelae among those who experience breakthrough infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
News Medical Life Sciences, 2021-10-28 04:41:57

New system created for targeted delivery of anti-cancer drugs
RUDN University and Shahid Beheshti University (SBU) chemist together with colleagues from Iran created a system for targeted delivery of anti-cancer drugs.
News Medical Life Sciences, 2021-10-28 03:18:00

A low-cost repurposed drug can save COVID-19 patients' lives
An inexpensive repurposed drug called fluvoxamine can save the lives of COVID-19 patients and cut hospital admissions by up to 30 per cent, says a study co-led by McMaster University.
News Medical Life Sciences, 2021-10-28 03:14:00

Space Biology: A Road to the Moon, Mars, and Beyond
It’s an exciting time in the field of space travel research. In 2019, SpaceX launched its Dragon spacecraft and Boeing launched its CST-100 Starliner. Both are designed to one day carry human passengers to their destination and home again. These launches represent a critical milestone towards NASA’s return to launching American astronauts to space from American soil using American commercial spacecraft.
ORB Company Blog, 2020-02-26 22:19:00

Survey: Young adults with chronic pain more likely to use cannabis or CBD oil to manage the condition
Young adults, ages 18-34, are more likely to report experiencing chronic pain compared to older adults (65% vs. 52% ages 35+), with a large majority of them (73%) saying they are in pain every day, according to a new survey conducted online by The Harris Poll on behalf of the Samueli Foundation.
News Medical Life Sciences, 2021-10-28 02:59:30

New mechanisms for treating impregnable KRAS mutant cancers with statins
Third-generation cancer immunotherapy, a method of removing cancer using the body's immune system, has shown remarkable clinical benefits in recent years, giving hopes to many researchers and patients.
News Medical Life Sciences, 2021-10-28 02:52:06